Answers are grounded in this paper and cite their sources.
CP‐94,253, 3‐(1,2,5,6‐tetrahydro‐4‐pyridyl)‐5‐propoxypyrrolo[3,2‐ b ]pyridine, a new serotonergic ligand, was found to exhibit significantly greater binding affinity at 5‐HT 1B receptors than at 5‐HT 1A or 5‐HT 1C receptors. Saturation studies showed CP‐94,253 to be a competitive inhibitor of [ 125 l]iodocyanopindolol binding to 5‐HT 1B sites. Its competition curve with this radioligand was shifted to the right (decreased affinity) in the presence of Gpp(NH)p, indicating an agonist function for CP‐94,253. Oral administration of CP‐94,253 to rats caused inhibition of food intake, decrease in body weight gain, and hyperlocomotion, effects apparently elicited via activation of 5‐HT 1B receptors.
No takes yet. Share an insight, caveat, or question.
Koe et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: